Novel approach for advanced personalized cancer treatment

Anna Luise Grab, Ramesh Utharala, Thorsten Cramer, Julio Saez-Rodrigue, Nicolas Peschke, Denes Türei, Wenwei Ma, Vida Vafaizdah, Federica Eduati, Christoph Merten

Research output: Chapter in Book/Report/Conference proceedingConference contributionAcademicpeer-review

Abstract

The global incidence rate of cancer cases increases with 18 Mio. (2018) new diagnosis a year. Most patients get a standard therapy, which is often not the best fit. The key problem is that each patient and each tumor responses differently to drugs. Here we address solid tumor biopsies from colon cancer patients. We present high-throughput drug-screening, which allows to determine the efficiency of individual and combinatorial drugs, including antibodies, pathway inhibitors or cytokines to recommend the best personalized therapy for the patient.

Original languageEnglish
Title of host publicationMicroTAS 2020 - 24th International Conference on Miniaturized Systems for Chemistry and Life Sciences
PublisherChemical and Biological Microsystems Society
Pages270-271
Number of pages2
ISBN (Electronic)9781733419017
Publication statusPublished - 2020
Event24th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2020 - Virtual, Online
Duration: 4 Oct 20209 Oct 2020

Conference

Conference24th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2020
CityVirtual, Online
Period4/10/209/10/20

Keywords

  • Best Personalized Therapy
  • Cancer Cell Apoptosis
  • Cell Signaling
  • High-Throughput Drug Screening

Fingerprint Dive into the research topics of 'Novel approach for advanced personalized cancer treatment'. Together they form a unique fingerprint.

Cite this